Fig. 4
Incidence of dyslipidemia per ART regimen found in individual studies. Incidence of hypercholesterolemia, hypertriglyceridemia, and undefined dyslipidemia per antiretroviral treatment (ART) regimen. NRTI nucleoside reverse transcriptase inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitor, PI protease inhibitor, cART combined antiretroviral treatment. Grading of dyslipidemia according to DAIDS [39], or non-graded incidence of dyslipidemia not specifying the definition of ‘dyslipidemia.’ (crosses) [31, 32, 41]